InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by FIL Ltd. Director active across 3 companies, notably Xilio Therapeutics, Inc.. Cumulatively, 3 disclosures have been recorded. Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
FIL Ltd is a declarant linked to Bicara Therapeutics Inc., Structure Therapeutics Inc. and Xilio Therapeutics, Inc. The record shows 4 filings in total, with sampled filings dated from 2021-10-28 to 2024-09-18, and no buy or sell amount indicated in this sample.